martindale.com
Legal Library
|
Duane Morris LLP Atlanta, GA Document Search Results (6) Sort by:  | Federal Circuit Addresses Infringement of Method-of-Use Patents by Generics in Yasmin® Case
Kristina Caggiano, Vincent L. Capuano, Michele A. Kliem, Matthew C. Mousley; Duane Morris LLP;
Legal Alert/Article April 23, 2012, previously published on April 18, 2012 The U.S. Court of Appeals for the Federal Circuit on April 16, 2012, in Bayer Schering Pharma AG v. Sandoz, Inc., Nos. 2011-1143, -1228 (YASMIN®), affirmed a district court's holding that as a matter of law, generic drug makers could not infringe patent claims reciting a method of use of an...
| | Motion for Sanctions Granted for Failure to Comply with Discovery Obligations to Designate Witness Under Federal Rule of Civil Procedure 30(b)6
Steven D. Ginsburg, Warren D. Zaffuto; Duane Morris LLP;
Legal Alert/Article February 22, 2012, previously published on February 21, 2012 Duane Morris recently obtained an order from U.S. Magistrate Judge Jonathan Goodman in the U.S. District Court for the Southern District of Florida granting a motion for sanctions against QBE Insurance Corporation ("QBE") for failure to comply with a corporation's discovery obligations to...
| | FDA Issues Draft Guidance Documents to Implement the Biologics Price Competition and Innovation Act of 2009
W. Blake Coblentz, Lee Crews, L. Norwood "Woody" Jameson, Vicki G. Norton, Siegfried J.W. Ruppert; Duane Morris LLP;
Legal Alert/Article February 15, 2012, previously published on February 13, 2012 On February 9, 2012, the U.S. Food and Drug Administration (FDA) issued eagerly anticipated draft guidance documents on biosimilar product development in three installments, collectively the "Biosimilar Draft Guidances":
| | FDA Sends Prescription Drug User Fee Act V to Congress for Reauthorization
Lee Crews, L. Norwood "Woody" Jameson, Vicki G. Norton, Siegfried J.W. Ruppert; Duane Morris LLP;
Legal Alert/Article January 24, 2012, previously published on January 23, 2012 The Prescription Drug User Fee Act (PDUFA) allows the U.S. Food and Drug Administration (FDA) to collect fees from drug manufacturers to facilitate reviewing their new drug applications. In a statement released January 13, 2012, the FDA said it had completed and transmitted to Congress for...
| | Florida Appellate Court Restricts Foreclosure Summary Judgment Affidavit from Bank That Relies on Data from a Computer System as Inadmissible Hearsay
Steven D. Ginsburg, Barry D. Lapides; Duane Morris LLP;
Legal Alert/Article October 18, 2011, previously published on October 17, 2011 The Florida Fourth District Court of Appeal recently issued an opinion in Glarum v. LaSalle Bank Nat'l Ass'n—2011 Fla. App. LEXIS 14039; 2011 WL 3903161 (Fla. Dist. Ct. App. 4th Dist., Sept. 7, 2011)—that strictly applied the business records exception in a residential foreclosure case....
| | Supreme Court Affirms Heightened Burden of Proof to Invalidate Patents
Robert H. Dietrick, Lewis F. Gould, L. Norwood "Woody" Jameson, Christopher J. Tyson; Duane Morris LLP;
Legal Alert/Article June 13, 2011, previously published on June 10, 2011 In a unanimous decision issued on June 9, 2011, the U.S. Supreme Court affirmed the Federal Circuit's holding in Microsoft v. i4i Limited Partnership that clear and convincing evidence is required to overcome the presumption of validity to issued patents, codified in section 282 of the Patent Act....
|
|